The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Philip Thomas was a 10-year-old pupil at Pantglas Junior School in Aberfan when a coal tip collapsed and slid downhill.
ITV News speaks to Jeff Edwards - who was eight years old when he became the last survivor to be pulled from the rubble.
Until 21st October 1966, Aberfan was a place that most of the world had never heard of.